{"id":"https://openalex.org/W179098388","doi":null,"title":"Structural interaction between drug - DNA and protein- A novel approach for bioinformatics in medicine","display_name":"Structural interaction between drug - DNA and protein- A novel approach for bioinformatics in medicine","alternate_titles":[],"publication_year":2009,"publication_date":"2009-01-01","ids":{"openalex":"https://openalex.org/W179098388","mag":"179098388"},"language":"en","primary_location":{"id":"mag:179098388","doi":null,"is_oa":false,"landing_page_url":"https://www.abacademies.org/structural-interaction-between-drug--dna-and-protein-a-novel-approach-for-bioinformatics-in-medicine.pdf","pdf_url":null,"source":{"id":"https://openalex.org/S90794122","display_name":"Biomedical Research-tokyo","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core"],"host_organization":"https://openalex.org/P4322697010","host_organization_name":"Biomedical Research Foundation","host_organization_lineage":["https://openalex.org/P4322697010"],"host_organization_lineage_names":["Biomedical Research Foundation"],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Biomedical Research-tokyo","raw_type":null},"parent_works":[],"lineage":["https://openalex.org/W179098388"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5072140760","display_name":"Ajit Kumar Saxena","orcid":"https://orcid.org/0000-0001-9146-2013","observed_orcids":["https://orcid.org/0000-0001-9146-2013"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Ajit Kumar Saxena","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014236716","display_name":"Divya Ramesh Singh","orcid":"https://orcid.org/0000-0002-2487-4082","observed_orcids":["https://orcid.org/0000-0002-2487-4082"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Divya Singh","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":null,"display_name":"Gajendra Singh","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Gajendra Singh","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.117,"has_fulltext":false,"cited_by_count":11,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.32552532,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":86,"max":95},"biblio":{"volume":"20","issue":"1","first_page":"0","last_page":null},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10211","display_name":"Computational Drug Discovery Methods","score":0.8339999914169312,"subfield":{"id":"https://openalex.org/subfields/3002","display_name":"Drug Discovery"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10211","display_name":"Computational Drug Discovery Methods","score":0.8339999914169312,"subfield":{"id":"https://openalex.org/subfields/3002","display_name":"Drug Discovery"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10044","display_name":"Protein Structure and Dynamics","score":0.1281999945640564,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11908","display_name":"Protein Interaction Studies and Fluorescence Analysis","score":0.023399999365210533,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/methotrexate","display_name":"methotrexate","score":1.0},{"id":"https://openalex.org/keywords/drug-dna-interaction","display_name":"drug-DNA interaction","score":0.859000027179718},{"id":"https://openalex.org/keywords/drug-protein-interactions","display_name":"drug-protein interactions","score":0.8100000023841858},{"id":"https://openalex.org/keywords/dihydrofolate-reductase","display_name":"dihydrofolate reductase","score":0.996999979019165},{"id":"https://openalex.org/keywords/homology-modeling","display_name":"homology modeling","score":0.8880000114440918},{"id":"https://openalex.org/keywords/protein-structure-prediction","display_name":"protein structure prediction","score":0.5690000057220459},{"id":"https://openalex.org/keywords/drug-binding-sites","display_name":"drug binding sites","score":0.4659999907016754},{"id":"https://openalex.org/keywords/antifolate-drugs","display_name":"antifolate","score":0.7009999752044678},{"id":"https://openalex.org/keywords/anticancer-agents","display_name":"anticancer agents","score":0.777999997138977},{"id":"https://openalex.org/keywords/drug-toxicity","display_name":"drug toxicity","score":0.6710000038146973}],"concepts":[{"id":"https://openalex.org/C2781320022","wikidata":"https://www.wikidata.org/wiki/Q417149","display_name":"Dihydrofolate reductase","level":3,"score":0.8647133708000183},{"id":"https://openalex.org/C169627665","wikidata":"https://www.wikidata.org/wiki/Q5767913","display_name":"Homology modeling","level":3,"score":0.6301209926605225},{"id":"https://openalex.org/C2781059491","wikidata":"https://www.wikidata.org/wiki/Q422232","display_name":"Methotrexate","level":2,"score":0.610668420791626},{"id":"https://openalex.org/C552990157","wikidata":"https://www.wikidata.org/wiki/Q7430","display_name":"DNA","level":2,"score":0.5396355390548706},{"id":"https://openalex.org/C192071366","wikidata":"https://www.wikidata.org/wiki/Q2991682","display_name":"Drug design","level":2,"score":0.4918961524963379},{"id":"https://openalex.org/C70721500","wikidata":"https://www.wikidata.org/wiki/Q177005","display_name":"Computational biology","level":1,"score":0.4882183372974396},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.44932302832603455},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.4439944922924042},{"id":"https://openalex.org/C167625842","wikidata":"https://www.wikidata.org/wiki/Q899763","display_name":"Peptide sequence","level":3,"score":0.4198874235153198},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.3876394033432007},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.3404321074485779},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.3353508710861206},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.17743250727653503},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.06751689314842224},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"mag:179098388","doi":null,"is_oa":false,"landing_page_url":"https://www.abacademies.org/structural-interaction-between-drug--dna-and-protein-a-novel-approach-for-bioinformatics-in-medicine.pdf","pdf_url":null,"source":{"id":"https://openalex.org/S90794122","display_name":"Biomedical Research-tokyo","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core"],"host_organization":"https://openalex.org/P4322697010","host_organization_name":"Biomedical Research Foundation","host_organization_lineage":["https://openalex.org/P4322697010"],"host_organization_lineage_names":["Biomedical Research Foundation"],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Biomedical Research-tokyo","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.5683000087738037,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":6,"referenced_works":["https://openalex.org/W1503386326","https://openalex.org/W2013275704","https://openalex.org/W2081201480","https://openalex.org/W2134259738","https://openalex.org/W2136241503","https://openalex.org/W2138749624"],"related_works":["https://openalex.org/W2276908415","https://openalex.org/W2039095798","https://openalex.org/W1509635893","https://openalex.org/W2016700447","https://openalex.org/W2929471045","https://openalex.org/W29328981","https://openalex.org/W2760994648","https://openalex.org/W2094379014","https://openalex.org/W2055009933","https://openalex.org/W2403730362"],"abstract_inverted_index":{"Drug":[0],"like":[1],"methotrexate":[2,108],"were":[3,249],"used":[4,29,145,220],"in":[5,43,146,208,235,256,273,289],"the":[6,54,58,87,147,165,176,193,200,209,227,236,240,244,263],"present":[7,148,237],"study":[8,99,149,238],"because":[9,71],"of":[10,21,57,72,74,89,106,121,127,153,164,178,195,202,226,230,266,297],"dual":[11],"importance,":[12],"both":[13],"for":[14,30,86,150,175],"clinicians":[15],"as":[16,18,32,34,116,118,141,186],"well":[17,33,117],"an":[19,25,82,203],"interest":[20],"basic":[22],"scientists.":[23],"Methotrexate,":[24],"antineoplastic":[26],"agent":[27],"is":[28,100],"malignant":[31,36],"non":[35],"conditions":[37],"and":[38,61,112,198,215,246,259,282],"become":[39],"teratogenic":[40],"&":[41],"mutagenic":[42],"nature.":[44],"They":[45],"prevent":[46],"cell":[47],"proliferation":[48],"by":[49,78,167],"incorporated":[50],"into":[51],"DNA":[52],"during":[53],"S-":[55],"phase":[56],"cell-":[59],"cycle":[60],"inhibit":[62],"rapidly":[63],"dividing":[64],"normal":[65],"somatic":[66],"cell-division":[67],"including":[68],"germ":[69],"cells":[70],"antagonist":[73],"folic":[75,90],"acid":[76,91,159],"synthesis":[77],"inhibiting":[79],"dihydrofolate":[80,113],"reductase":[81,114],"essential":[83],"enzyme":[84],"required":[85],"conversion":[88],"to":[92,101,110,161,192,221,292,294],"tetrahydrofolic":[93],"acid.":[94],"The":[95,212],"rational":[96],"behind":[97],"this":[98],"observe":[102],"binding":[103],"sites":[104],"activity":[105,163],"native":[107],"structure":[109,120,135,194,217],"DNA,":[111],"(protein)":[115],"mutated":[119],"drug":[122,131,166,231,245,298],"(methotrexate)":[123,132],"using":[124],"different":[125],"software":[126],"structural":[128,168,224],"modeling.":[129],"For":[130],"-":[133],"protein":[134,155,183],"interaction,":[136],"homology":[137,171],"modeling,":[138,143],"also":[139],"known":[140,182],"comparative":[142],"was":[144],"constructing":[151],"model":[152,225],"a":[154,223],"from":[156],"its":[157],"amino":[158],"sequence":[160,213,265],"enhance":[162],"modification.":[169],"All":[170],"modeling":[172],"techniques":[173],"help":[174],"identification":[177],"one":[179],"or":[180,188,232],"more":[181],"structures":[184],"(known":[185],"templates":[187],"parent":[189],"structures)":[190],"resemble":[191],"query":[196,210,264],"sequence,":[197],"on":[199],"production":[201],"alignment,":[204],"which":[205,251,287],"maps":[206],"residues":[207,279],"sequence.":[211],"alignment":[214],"template":[216],"are":[218,280],"then":[219],"produce":[222],"target":[228],"site":[229],"protein.":[233],"Interestingly":[234],"indicates":[239],"significant":[241],"interaction":[242],"between":[243],"DNA/":[247],"proteins":[248],"noticed":[250],"could":[252],"be":[253],"further":[254],"useful":[255],"reaching":[257],"qualitative":[258],"quantitative":[260],"conclusions":[261],"about":[262,276],"developing":[267],"new":[268],"molecule":[269],"(drug":[270],"action),":[271],"especially":[272],"formulating":[274],"hypotheses":[275,296],"why":[277],"certain":[278],"conserved":[281],"making":[283],"toxic":[284],"side":[285],"effects":[286],"may":[288],"turn":[290],"lead":[291],"experiments":[293],"test":[295],"mediated":[299],"toxicity.":[300]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W179098388","counts_by_year":[{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":2},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":1}],"updated_date":"2026-11-21T10:27:49.728292","created_date":"2016-06-24T00:00:00"}
